ANTI-CD25 ANTIBODY AGENTS

BISPECIFIC TETRAVALENT ANTIBODY TARGETING EGFR AND HER3

METHODS AND COMPOSITIONS FOR DECREASING SOLUBLE IMMUNE RECEPTOR CD28

MODULATION OF ANDROGEN SIGNALING TO INNATE IMMUNE KILLING OF PROSTATE CANCER

ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE

TUMOR HOMING AND CELL PENETRATING PEPTIDE-IMMUNO-ONCOLOGY AGENT COMPLEXES AND METHODS OF USE THEREOF

PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM

THERAPEUTICALLY ACTIVE STEROIDAL DERIVATIVES

PHOSPHORAMIDATES FOR THE TREATMENT OF HEPATITIS B VIRUS

SELECTIVE CYCLIN-DEPENDENT KINASE INHIBITORS AND METHODS OF THERAPEUTIC USE THEREOF

PYRAN DERIVATIVES AS CYP11A1 (CYTOCHROME P450 MONOOXYGENASE 11A1) INHIBITORS

HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER

PROTEIN KINASE C INHIBITORS AND METHODS OF THEIR USE

PHOSPHODIESTERASE 3 (PDE3) INHIBITORS

METHODS FOR THE TREATMENT OF DIABETIC RETINOPATHY AND OTHER OPHTHALMIC DISEASES

RADIOLABELED PARP INHIBITOR CONJUGATES FOR CANCER TREATMENT

SUBCUTANEOUSLY ADMINISTERED ANTIBODY-DRUG CONJUGATES FOR USE IN CANCER TREATMENT

Methods and Compositions for Treating Cancer

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

COMPOSITIONS AND METHODS OF TREATING SARCOMA LUNG METASTASIS

AAV9-MEDIATED GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE I

METHOD AND PHARMACEUTICAL COMBINATION FOR PREVENTING CANCER RECURRENCE

ANNEXIN TO INHIBIT BACTERIA

METHODS AND COMPOSITIONS FOR HIGH-POTENCY POLYPEPTIDE-BASED PROTEIN INHIBITION

MELFLUFEN FOR USE IN THE TREATMENT OF MULTIPLE MYELOMA

Fagopyrum Nutraceutical Compositions

ARMED SENECA VALLEY VIRUS ONCOLYTIC THERAPY COMPOSITIONS AND METHODS THEREOF

Methods and Compositions Relating to Microbial Treatment and Diagnosis of Disorders

COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

Composition for inducing proliferation or accumulation of regulatory T cells

Mammalian cell population and medicaments for cell therapies in canines and improved cell cultivation methods

COMPOSITIONS, DEVICES AND METHODS FOR TREATING IMMUNE-MEDIATED INFLAMMATORY DISEASES

MAMMALIAN CELL POPULATION AND MEDICAMENTS FOR CELL THERAPIES IN EQUINES AND IMPROVED CELL CULTIVATION METHODS

SYNERGISTIC COMPOSITION FOR MAINTENANCE OF HEALTHY BALANCE OF MICROFLORA

METHODS FOR TREATING INFLAMMATORY PAIN AND BONE DECALCIFICATION

Device for determining the attitude of a carrier, and associated system for assisting with the piloting of a carrier and determination method

Composition for Treatment of Muscular Disorders

DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION

FORMULATIONS FOR SUBSTITUTED 3-PYRROLIDINES, COMPOSITIONS CONTAINING, AND USES OF SAME

NOVEL METHODS

NOVEL COMPOUNDS

PYRAZINE-CONTAINING COMPOUND

MODULATORS OF THE INTEGRATED STRESS PATHWAY

METHODS OF USE AND COMPOSITIONS OF BISBENZYLISOQUINOLINES FOR THE TREATMENT OF MALIGNANCIES

COMPOSITIONS AND METHODS TO IMPROVE BENEFIT OF SUBOPTIMALLY ADMINISTERED THERAPEUCTICS FOR THE TREATMENT OF BENIGN AND NEOPLASTIC DISEASES, INFECTIONS, INFLAMMATORY, METABOLIC AND IMMUNOLOGIAL DISEASES

BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2

SIGMA RECEPTOR LIGANDS FOR TREATING SARS-COV-2 INFECTION

Exo VII Inhibitor and Quinolone Antibiotic Combination Useful for Treating Bacterial Infection

USE OF HSP70 AS A REGULATOR OF ENZYMATIC ACTIVITY

4H-PYRROLO[3,2-c]PYRIDIN-4-ONE COMPOUNDS

COMPOSITIONS COMPRISING CANNABINOIDS AND METHODS OF USE

COMPOSITIONS COMPRISING CANNABINOIDS AND METHODS OF USE

ANTI-VIRAL THERAPEUTIC AGENTS AND USES THEREOF

COMPOSITIONS AND METHODS FOR MODULATING HEXIM1 EXPRESSION

Mirdametinib treatment

Mirdametinib treatment

MIRDAMETINIB TREATMENT

DUAL RELEASE DOSAGE FORM CAPSULE AND METHODS, DEVICES AND SYSTEMS FOR MAKING SAME

FORMULATIONS OF ACTIVE PHARMACEUTICAL INGREDIENTS (APIs) FOR LOCAL DELIVERY VIA ACTIVE MICROBOT

POLYFUNCTIONAL RADICAL SCAVENGER HYDROGEL FORMULATION

DEVICE AND METHOD FOR TREATING CANCER

Combination Therapy to Treat Temperature Sensitive Mutant Tumors

CLOTTABILITY-BASED PERSONALIZED TREATMENT (CPT) SYSTEM

Method for Diagnosing and Assessing Endometriosis

URINARY TRACT CANCER TREATMENT GUIDED BY MUTATIONAL LANDSCAPE

Treatment for Skeletal Diseases Caused by Intracellular Protein Trafficking Defects

METHODS AND COMPOSITIONS FOR TREATING A PROPROTEIN CONVERTASE SUBTILISIN KEXIN (PCSK9) GENE-ASSOCIATED DISORDER

Ligand Binding Molecules and Uses Thereof

ONCOLYTIC VIRUS STRAIN

METHODS OF TREATING CANCERS AND ENHANCING EFFICACY OF T CELL REDIRECTING THERAPEUTICS

LTBP COMPLEX-SPECIFIC INHIBITORS OF TGFb1 AND USES THEREOF

METHODS FOR THE TREATMENT OF THYROID EYE DISEASE

BISPECIFIC ANTIBODY AND USE THEREOF

ANTI-STAPHYLOCOCCUS ANTIBODIES AND USES THEREOF

TREATMENT OF INTESTINAL LUMEN IMMUNOGLOBULIN DEFICIENCY WITH SEMISYNTHETIC POLYCLONAL HUMAN SECRETORY IMMUNOGLOBIN A

TREATMENT OF MAGE-A4 POSITIVE CANCER

T CELL RECEPTORS THAT BIND TO MIXED LINEAGE LEUKEMIA (MLL)-SPECIFIC PHOSPHOPEPTIDES AND METHODS OF USE THEREOF

GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF

NOVEL PEPTIDES AND USES THEREOF FOR TREATING CANCER

COMPOUNDS AS MODULATORS OF ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1 (ERAP1)

THIOPHENE-BASED LIPIDS

Crystalline forms of N[4[4-(4-Morpholinyl)-7H-Pyrrolo[2-3-D]Pyrimidin-6-yl]Phenyl]-4-[[3(R)-[(1-Oxo-2-Protein-1-yl)Amino]-1-Piperidinyl]Methyl]2-Pyridinecarboxamide]

HPK1 INHIBITORS, PREPARATION METHOD AND APPLICATION THEREOF

Composition and Methods for Treating Attention Deficit Disorders

Indole-substituted quinolines and their combination with Plk1 inhibitors for the treatment of cancer

MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS

HYDROGEL INCLUDING PHENOL DERIVATIVE-MODIFIED CELLULOSE AND USE THEREOF

CANCER THERANOSTIC COMPOSITIONS COMPRISING BIGUANIDE COMPLEXES OF GROUP 7 TRANSITION METALS AND USES THEREOF

ANTIBODIES TO PMEL17 AND CONJUGATES THEREOF

ANTI-FOLR1 IMMUNOCONJUGATES AND ANTI-PD-1 ANTIBODY COMBINATIONS

HYBRID RECEPTORS WITH MULTIPLE TRANSCRIPTIONAL REGULATORS

MINI CIRCULAR RNA THERAPEUTICS AND VACCINES AND METHODS OF USE THEREOF

NOVEL COMBINATIONS FOR ANTIGEN BASED THERAPY

ANTIBODY-GUIDED PCSK9-MIMICKING IMMUNOGENS LACKING 9-RESIDUE SEQUENCE OVERLAP WITH HUMAN PROTEINS

Methods and Compositions for Treating Diabetes

IMMUNOMODULATION FOR THE LONG TERM PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASES AND FOREIGN TISSUE REJECTION

COMBINATION THERAPIES WITH SIRP ALPHA-BASED CHIMERIC PROTEINS

Lisinopril formulations

DILEUCINE COMPOSITIONS AND METHODS OF USE THEREOF

TARGETS AND BIOMARKERS FOR TUMOR MICROENVIRONMENTS

USE OF A BIRNAVIRUS ALONE OR IN COMBINATION THERAPY FOR THE TREATMENT OF CANCER

AMMONIA OXIDIZING MICROORGANISMS FOR THE REGULATION OF BLOOD PRESSURE

ANTIGEN-AGNOSTIC COMBINATION IMMUNOTHERAPY

TARGETING B CELL ACTIVATING FACTOR RECEPTOR (BAFF-R) USING LIGAND-BASED CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS

Treatment of hearing loss

NEW SYNTHETIC AGONISTS OF TLR4 RECEPTOR

FLEX-NUCLEOSIDE ANALOGUES, NOVEL THERAPEUTICS AGAINST FILOVIRUSES AND FLAVIVIRUSES

TOPICAL TREATMENT OF WOUNDS WITH STATINS AND CHOLESTEROL FOR SCAR REDUCTION

COMPOSITIONS COMPRISING BISFLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS FOR TREATING CANCER

TREATMENT OF CEREBRAL CAVERNOUS MALFORMATIONS AND CEREBRAL ANEURYSMS WITH RHO KINASE INHIBITORS

Transcription Factor GLI1 Inhibitors and Uses Thereof

USE OF A DPP-4 INHIBITOR IN PODOCYTES RELATED DISORDERS AND/OR NEPHROTIC SYNDROME

REHYDRATION COMPOSITION AND METHOD OF USE

COMPOUNDS AND METHODS FOR TREATMENT OF DIAMOND BLACKFAN ANEMIA

ERK1/2 AND SHP2 INHIBITORS COMBINATION THERAPY

USE OF MEVIDALEN AND OTHER D1 POSITIVE ALLOSTERIC MODULATORS IN THE TREATMENT OF HALLUCINATIONS AND DEMENTIA-RELATED PSYCHOSIS

METHODS OF TREATING HEPATIC ENCEPHALOPATHY

IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE

EXOSOME PACKAGING AND TARGETED AUTOPHAGY

PHARMACEUTICAL COMBINATION, COMPOSITION AND COMPOUND PREPARATION COMPRISING GLUCOKINASE ACTIVATOR AND DPP-IV INHIBITOR, AND PREPARATION METHOD AND USE THEREOF

COMBINATION THERAPIES WITH SETD2 INHIBITORS

MODULATORS OF TRPML, THEIR COMPOSITIONS AND METHODS OF USE

SHELF-STABLE FORMULATIONS OF BENZOYL PEROXIDE AND METHODS OF PRODUCING SAME

CELLULAR ENERGY INHIBITOR FORMULATIONS FOR THE TREATMENT OF PATHOGENIC INFECTIONS AND ASSOCIATED METHODS

METHODS TO SENSITIZE CANCER CELLS AND STANDARDIZED SCREENING ASSAY FOR IMMUNOTHERAPY

DRUG DELIVERING NANO DEVICES AND METHODS OF SYNTHESIZING AND CURING CANCERS USING THE SAME

LIPID NANOPARTICLES AND METHOD FOR PREPARING SAME

COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF IMMUNOTHERAPIES AND VACCINES

Oral rinse, nasal spray and methods for prevention of COVID-19 by lowering viral load of COVID-19

STABLE SEMI-SOLID CHEWABLE GEL COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF

DEVICES, METHODS AND USES FOR REMOVING HEAT, ENERGY AND FLUIDS FROM A MAMMAL

Compounds For Molecular Imaging of Collagen Turnover and Methods Using Same

NEW CONJUGATED NUCLEIC ACID MOLECULES AND THEIR USES

Method of Treatment for Auditory Dysfunction

ATXN2 IRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING ATXN2-ASSOCIATED NEURODEGENERATIVE DISEASES

VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES

Reprogrammed T Cell-Like NK Cells

ANTIBODIES TO CHITINASE 3-LIKE-1 AND METHODS OF USE THEREFOR

HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR

Method and Compositions for Inducing Differentiation of Myeloid Derived Suppressor Cell to Treat Cancer and Infectious Diseases

ANTIGEN BINDING MOLECULES THAT BIND LIGHT

IL-17 RECEPTOR A ANTIGEN BINDING PROTEINS

ANTIBODIES

ANTI-VTCN1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES

COMPOSITIONS AND METHODS FOR MODULATING CANCER IMMUNE FITNESS

ANTI-NKG2A ANTIBODIES AND COMPOSITIONS

TGF-BETA INHIBITORS AND THERAPEUTIC USE THEREOF

NOVEL ANTI-GREMLIN1 ANTIBODIES

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

INSULIN RECEPTOR PARTIAL AGONISTS

ANALGESIC AND ANESTHETIC PEPTIDES AND OTHER AGENTS

CD206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linker

DEGRADABLE POLYMERS OF A CYCLIC SILYL ETHER AND USES THEREOF

A CLASS OF FUSED RING COMPOUNDS, AND PREPARATION AND USE THEREOF

Biologically Active Taxane Analogs and Methods of Treatment by Oral Administration

SMALL MOLECULES AS MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS, COMPOSITIONS AND USE THEREOF

2-HETEROARYL-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES FOR THE TREATMENT OF CANCER

TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN

GluN2C/D Subunit Selective Antagonists of the N-Methyl-D-Aspartate Receptor

LOW MOLECULAR WEIGHT PROTEIN DEGRADERS AND THEIR APPLICATIONS

INHIBITORS OF THE IRE-1/XBP-1 PATHWAY AND METHODS OF USING THEREOF

COMPOSITIONS FOR TREATING AND/OR PREVENTING CELL OR TISSUE NECROSIS SPECIFICALLY TARGETING CATHEPSIN C AND/OR CELA1 AND/OR CELA3A AND/OR STRUCTURALLY RELATED ENZYMES THERETO

ROS-RESPONSIVE CAPTOPRIL-CINNAMALDEHYDE PRODRUGS AND COMPOSITIONS AND METHODS THEREOF

RADIOPAQUE CROSSLINKED ACRYLAMIDE COPOLYMERS AND USES THEREOF

Composition Comprising Trim31 and Rhbdf2 for Treatment of NAFLD/NASH

ANTI-EGFRvIII ANTIBODY DRUG CONJUGATES AND USES THEREOF

LOCALIZED DELIVERY OF ANTI-FUGETACTIC AGENT FOR TREATMENT OF CANCER

METHOD FOR PROPHYLAXIS AND/OR TREATMENT OF ErbB2 POSITIVE CANCERS

Immune checkpoint inhibitor combinations

PLANT EXTRACTS WITH ANTI-DIABETIC AND OTHER USEFUL ACTIVITIES

Compositions For and Methods of Promoting Respiratory Health

METHODS AND COMPOSITIONS FOR PREDICTING CANCER SURVIVAL AND CAR T CELL TOXICITY

AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF DIAPER RASH, ATHLETE’S FOOT, CONTACT DERMATITIS, PERSPIRATION, AND BODY ODOR

Bee Product Extracts, Methods of Production, and Uses Thereof

FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS

FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS

3-SUBSTITUTED PIPERIDINE COMPOUNDS FOR CBL-B INHIBITION, AND USE THEREOF

COMPOSITIONS AND METHODS OF ENHANCING ANTI-TUMOR RESPONSE USING HYBRID NEUTROPHILS

Materials and Methods for Prevention and Treatment of Diarrhea and Inflammation in the Gastrointestinal Tract

COMBINATION THERAPY EFFECTIVE AGAINST MICROORGANISMS, INCLUDING DRUG RESISTANT MICROORGANISMS

SHP2 AND CDK4/6 INHIBITORS COMBINATION THERAPIES FOR THE TREATMENT OF CANCER

COMBINATION THERAPY FOR TREATING CANCER

COMPOUND AND METHOD FOR TREATING CHEMOTHERAPY-RELATED GASTROINTESTINAL SIDE EFFECTS

COMPOSITIONS FOR TREATING SPINAL MUSCULAR ATROPHY

METHODS OF TREATING AND PREVENTING ALLOANTIBODY DRIVEN CHRONIC GRAFT VERSUS HOST DISEASE

METHODS OF TREATING AND PREVENTING GRAFT VERSUS HOST DISEASE

Treatment of Symptoms Associated with Myeloproliferative Neoplasms

NOVEL AZAINDOLE DERIVATIVES AS ANTIVIRAL AGENTS

GASTRO-RESISTANT HIGH-STRENGTH FORMULATION CONTAINING POSACONAZOLE

COMBINATION THERAPY FOR TREATMENT OF LIVER DISEASES

THERAPEUTIC AGENT FOR CANCER OF PATIENT WITH DECREASE IN RB1 FUNCTION USING MYT1 INHIBITOR AND CHEMOTHERAPEUTIC AGENT IN COMBINATION, AND TREATMENT METHOD THEREOF

METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS

PROPHYLACTIC OR THERAPEUTIC DRUG FOR PARKINSON'S DISEASE

Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders

Cannabinoid Formulations

METHOD OF TREATMENT

METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING A DISEASE OR A CONDITION

Non-vasoconstricting energy-promoting compositions containing ketone bodies

NONVIRAL GENE TRANSFER TO THE SUPRACHOROIDAL SPACE

PHARMACEUTICALLY STABLE SOFT CAPSULE COMPRISING TWO OR MORE DIFFERENT COMPOSITIONS

CLEAVABLE LINKER-CONTAINING IONIZABLE LIPIDS AND LIPID CARRIERS FOR THERAPEUTIC COMPOSITIONS

CROSSLINKED HYALURONIC ACID COMPOSITION WITH LOCAL ANESTHETICS

METHODS AND COMPOSITIONS OF CRYOABLATION WITH DRUG DELIVERY

SYSTEMS AND METHODS FOR MONITORING AND TREATING STROKE

BIOMARKERS PREDICTIVE OF CYTOKINE RELEASE SYNDROME

METHODS OF DETERMINING RISK OF AND TREATING CANCER RECURRENCE

GLUCOKINASE (GCK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS OF USE FOR MUTATED HOTAIR IN THE TREATMENT OF CANCERS

OLIGONUCLEOTIDES

TUMOR ANTIGEN-DEPENDENT CD40 AGONISTS ANTIBODIES

Anti-cub domain-containing protein 1 (CDCP1) antibodies, antibody drug conjugates, and methods of use thereof

BISPECIFIC ANTIBODY

BISPECIFIC PD-1 AND TIGIT BINDING PROTEINS AND USES THEREOF

COMPOSITIONS AND METHODS FOR PERMEABILIZING THE BLOOD BRAIN BARRIER

HIDE1 COMPOSITIONS AND METHODS

MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)

METHODS FOR TREATING SYSTEMIC SCLEROSIS

METHODS OF USE OF ANTI-IL-2 ANTIBODIES

A NOVEL COMPOUND ACTING AGAINST A SELECT GROUP OF BACTERIA

NOVEL INHIBITORS OF 17ß-HSD7 AND USES THEREOF

1'-CYANO NUCLEOSIDE ANALOGS AND USES THEREOF

ALKYLIDENE DERIVATIVES AS KRAS INHIBITORS

HIGH ACTIVITY STING PROTEIN AGONIST

FUSED HETEROCYCLIC DERIVATIVES

RHO KINASE INHIBITOR BA-1049 (R) AND ACTIVE METABOLITES THEREOF

SUBSTITUTED BENZODIAZOLES AND USE THEREOF IN THERAPY

TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME

E3 Ligase Inhibitors and Methods of Use Thereof

FLUORINATED TRYPTAMINE COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME

Compositions Comprising Oxidized Cellulose

ANTIBODY-CD4 CONJUGATES AND METHODS OF USING THE SAME

TARGETING SORTILIN

METHOD AND COMPOSITION FOR TREATING TUMORS

PROTECTIVE VACCINE ANTIGEN AGAINST STREPTOCOCCAL INFECTION

COMPOSITIONS AND METHODS FOR TREATING CANCER

GNE AS A THERAPEUTIC AGENT

EFPEGLENATIDE TO REDUCE RISK OF DEVELOPING CARDIOVASCULAR DISEASE OR RENAL DYSFUNCTION

Compositions comprising a cannabinoid and uses thereof

COMPOSITIONS AND METHODS FOR TREATING SKIN CONDITIONS

COMBINATION OF AN ONCOLYTIC VIRUS, AN ANTI-PD-1 INHIBITOR AND AN ACTIVATOR OF THE INNATE IMMUNE SYSTEM FOR USE IN THE TREATMENT OF PROSTATE CANCER

AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF PULMONARY HYPERTENSION

COMPOSITIONS OF NITRATES AND METHODS OF USE THEREOF

INJECTABLE ANTIBIOTIC FORMULATIONS AND USE THEREOF

COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF DISEASES UTILIZING TIRILAZAD SALTS

Cancer treatment

MODULATORS OF TOLL-LIKE RECEPTORS FOR THE TREATMENT OF HIV

ASSESSING AND TREATING PROSTATE CANCER

INHIBITORS OF TRYPTOPHAN DIOXYGENASES (IDO1 and TDO) AND THEIR USE IN THERAPY

COMBINATION THERAPY FOR TREATING PIK3CA-MUTATED CANCER

COMPOUND AND METHOD FOR TREATING CHEMOTHERAPY-ASSOCIATED GASTROINTESTINAL SIDE EFFECTS

ERK1/2 AND KRAS G12C INHIBITORS COMBINATION THERAPY

TRPA1 CHANNEL ANTAGONIST COMPOUND FOR USE IN DEGENERATIVE RETINAL DISEASES

PYRAZOLYL-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS

DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULATORS FOR USE IN THE TREATMENT OF COUGH

PHENOL RIBONUCLEOTIDE REDUCTASE (RNR) INHIBITORS AND USES THEREOF

TREATMENT FOR AUTOIMMUNE DISEASES

COMPOSITIONS COMPRISING AN AGONIST OF 5-HYDROXYTRYPTAMINE (5-HT) RECEPTOR SUBTYPE 3

MALLEABLE CONTROLLED RELEASE LOCAL ANESTHETIC WITH HEMOSTATIC COMPOSITION

Topical roflumilast formulation having improved delivery and plasma half-life

HUMAN THERAPEUTIC AGENTS

METHODS FOR TREATING BACTERIAL CELL POPULATIONS

PHARMACEUTICAL COMPOSITION COMPRISING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID

R-MDMA FOR TREATMENT OF PAIN

METHODS OF TREATING BONE INFECTIONS

USE OF (S)-3-AMINO-4-(DIFLUOROMETHYLENYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID IN THE TREATMENT OF DIABETES AND PRE-DIABETES

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER CACHEXIA

FUNCTIONAL THERAPEUTIC INDEX IN THE TREATMENT OF PERIPHERAL IMMUNE DYSFUNCTION

LIPID BILAYER COATED MESOPOROUS SILICA NANOPARTICLES WITH A HIGH LOADING CAPACITY FOR ONE OR MORE ANTICANCER AGENTS

INHALABLE RAPAMYCIN FORMULATION FOR TREATING AGE-RELATED CONDITIONS

ANTIHISTAMINES COMBINED WITH DIETARY SUPPLEMENTS FOR IMPROVED HEALTH

WILDLIFE SUPPLEMENTATION METHODS AND RELATED COMPOSITION

DETERMINING MILD TRAUMATIC BRAIN INJURY, RECOVERY AND TREATMENT

EARLY DETECTION AND INTERVENTION OF AT-RISK SUBJECTS FOR PRODROMAL PARKINSON'S DISEASE

USE OF GENETIC AND EPIGENETIC MARKERS TO DETECT CELL DEATH

FLUORESCENT PROBES

Methods and Compositions for Managing Vascular Conditions Using miR-483 Mimics and HIF1alpha Pathway Inhibitors

TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS

COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY

Treatment of Cardiovascular Disease with TREM-1 Antigen Binding Proteins

METHODS OF USE OF ANTI-IL-2 ANTIBODIES

DUAL SPECIFIC ANTIBODIES

METHODS FOR THE TREATMENT OF SCLERODERMA AND RELATED CONDITIONS

SIGLEC-9 ECD Fusion Molecules and Methods of Use Thereof

GLUCAGON ANALOG AND MEDICAL USE THEREOF

CYCLIC PEPTIDE ANTIBIOTICS

POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY

COMPOUNDS AND METHODS OF TREATING TUBERCULOSIS

FUSED HETEROCYCLIC DERIVATIVES

Heterocyclic compounds for the treatment of tuberculosis

DUAL WNT SIGNALING PATHWAY INHIBITORS AND AMPK ACTIVATORS FOR TREATMENTS OF DISEASE

CRYSTALLINE HYDROCHLORIDE SALTS OF SUBSTITUTED TRYPTAMINES

Compounds and methods for inhibiting CYP26 enzymes

SMALL MOLECULE COMPOUNDS

ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE

CXCR5, PD-1, AND ICOS EXPRESSING TUMOR REACTIVE CD4 T CELLS AND THEIR USE

COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR

SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID

PHARMACEUTICAL COMPOSITION COMPRISING MACROCOSINE COMPOUND AND METHOD FOR PREPARING MACROCOSINE COMPOUND

CYCLOSPORINE COMPOSITIONS AND METHODS OF USE

INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF